Related Experiment Video

Updated: May 19, 2026

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer

Jonathan A Ewald1, David F Jarrard

  • 1Department of Urology, University of Wisconsin School of Medicine and Public Health, Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI.

Translational Oncology
|September 1, 2012
PubMed

Insights

Therapy-induced senescence (TIS) mechanisms remain unclear. Researchers identified diaziquone (AZQ) as a robust TIS inducer, revealing Skp2

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Therapy-induced senescence (TIS) is a crucial cancer cell response, but its underlying mechanisms are not fully understood.
  • Current anticancer therapies often induce TIS inefficiently, highlighting the need for novel agents and mechanistic insights.

Purpose of the Study:

  • To characterize the mechanisms of TIS induced by the quinone diaziquone (AZQ).
  • To investigate the role of Skp2 and p27(Kip1) in AZQ-mediated TIS in prostate cancer cells.

Main Methods:

  • Utilized diaziquone (AZQ) and other senescence-inducing agents.
  • Screened cyclin-dependent kinase inhibitors in prostate cancer cell lines.
  • Investigated the role of Skp2 through overexpression and short hairpin RNA knockdown.
  • Analyzed p27(Kip1) induction and Skp2 cellular localization during TIS.

Main Results:

  • Diaziquone (AZQ) robustly induces TIS in vitro and in vivo.
  • p27(Kip1) is consistently induced in prostate cancer cells undergoing TIS.
  • Skp2 negatively regulates p27(Kip1) and its cytoplasmic translocation precedes decreased expression in senescent cells.
  • Skp2 overexpression inhibits AZQ-induced senescence and p27(Kip1) induction; Skp2 knockdown reduces proliferation but not complete senescence.

Conclusions:

  • Skp2 plays a regulatory role in TIS but is insufficient on its own to induce senescence.
  • Understanding Skp2's role offers potential therapeutic strategies for enhancing TIS in cancer treatment.

More Related Videos

Induction and Validation of Cellular Senescence in Primary Human Cells08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...